Oxcarbazepine Tablet, Film Coated
Product Images NDC 60687-733
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 60687-733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ahp72201
Ahp73301
Structural Formula (Structure)
Figure 1: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure1)
Figure 2: Kaplan-meier Estimates Of First Seizure Event Rate By Treatment Group (Figure2)
Figure 3: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure3)
Figure 4: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure4)
150 mg Oxcarbazepine Tablets Carton (150 mg Oxcarbazepine Tablets Carton)
150 mg Oxcarbazepine Tablet Blister (150 mg Blister 01)
300 mg Oxcarbazepine Tablets Carton (300 mg Oxcarbazepine Tablets Carton)
300 mg Oxcarbazepine Tablet Blister (300 mg Blister 01)
600 mg Oxcarbazepine Tablets Carton (600 mg Oxcarbazepine Tablets Carton)
600 mg Oxcarbazepine Tablet Blister (600 mg Blister 01)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.